Vasculitis assessment with [18F]FDG positron emission tomography;Place de la tomographie par émission de positrons (TEP) au [18F]FDG dans l'exploration et la surveillance des vascularites

Revue de Medecine Interne

Volumn 31, Issue 6, 2010, Pages 417-427

  Liozon, E ^a   Monteil, J ^a   Ly, K H ^a   Vidal, E ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

18F FDG positron emission tomography; Aortitis; Giant cell arteritis; Large vessel vasculitis; Takayasu's arteritis

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AORTA ARCH SYNDROME; AORTITIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; GIANT CELL ARTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; VASCULITIS; ARTERITIS; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; PREDICTIVE VALUE; SCINTISCANNING;

AORTITIS; ARTERITIS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TAKAYASU ARTERITIS; VASCULITIS;

EID: 77953617617     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.06.011     Document Type: Short Survey

References (113)

1. Vos F.J., Bleeker-Rovers C.P., Corstens F.H., Kullberg B.J., Oyen W.J. FDG-PET for imaging of nonosseous infection and inflammation. Q J Nucl Med Mol Imaging. 2006, 50:121-130.
2. Love C., Tomas M.B., Tronco G.G., Palestro C.J. FDG PET of infection and inflammation. Radiographics 2005, 25:1357-1368.
3. 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003, 30:1305-1313.
4. Pipitone N., Versari A., Salvarani C. Role of imaging studies in the diagnosis and follow-up of large vessel vasculitis: an update. Rheumatology 2008, 47:403-408.
5. Bleeker-Rovers C.P., Bredie S.J.H., van den Meer J.W.M., Corstens F.H.M., Oyen W.J.G. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003, 61:323-329.
6. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
7. Guillevin L., Pagnoux C. Classification des vascularites systémiques. Rev Prat 2008, 58:480-486.
8. Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant cell arteritis. Lancet 2008, 372:234-245.
9. Schmidt W.A., Kraft H.E., Vorpahl K., Völker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
10. Bley T.A., Wieben O., Uhl M., Thiel J., Schmidt D., Langer M. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 2005, 184:283-287.
11. Bley T.A., Reinhard M., Hauenstein C., Markl M., Warnatz K., Hetzel A., et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008, 58:2574-2578.
12. Généreau T., Lortholary O., Guillevin L., Cacoub P., Galezowski N., Chérin P., et al. Temporal 67gallium uptake is increased in temporal arteritis. Rheumatology 1999, 38:709-713.
13. Reitblat T., Ben-Horin C.L., Reitblat A. Gallium-67 SPECT scintigraphy may be useful in diagnosis of temporal arteritis. Ann Rheum Dis 2003, 62:257-260.
14. Reitblat T., Ben-Horin C.L., Reitblat A. Increased 67gallium uptake among polymyalgia rheumatica patients. Is it additional evidence of its vasculitic nature?. Rheumatol Int 2006, 26:1010-1013.
15. Weyand C.M., Goronzy J.J. Medium- and large vessel vasculitis. N Engl J Med 2003, 349:160-169.
16. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50years. Arthritis Rheum 2003, 48:3522-3531.
17. Agard C., Barrier J.H., Dupas B., Ponge T., Mahr A., Fradet G., et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008, 59:670-676.
18. Marie I., Proux A., Duhaut P., Primard E., Lahaxe L., Girszyn N., et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine 2009, 88:182-192.
19. Nuenninghoff D.M., Hunder G.G., Christianson T.J., McClelland R.L., Matteson E.L. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50years. Arthritis Rheum 2003, 48:3532-3537.
20. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis A population-based study. Ann Intern Med 1995, 122:502-507.
21. Garcia-Martinez A., Hernandez-Rodriguez J., Arguis P., Paredes P., Segarra M., Lozano E., et al. Development of aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of 54 prospectively followed patients. Arthritis Rheum 2008, 59:422-430.
22. Agard C., Ponge T., Hamidou M., Barrier J. Place des explorations vasculaires dans la maladie de Horton. Rev Rhum (Ed Fr) 2002, 69:702-708.
23. Narvaez J., Narváez J.A., Nolla J.M., Sirvent E., Reina D., Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology 2005, 44:479-483.
24. Schmidt W.A., Seifert A., Gromnica-Ihle E., Krause A., Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large vessel giant cell arteritis. Rheumatology 2008, 47:96-101.
25. Hervé F., Choussy V., Janvresse A., Cailleux N., Levesque H., Marie I. Aortite inflammatoire et maladie de Horton. À propos du suivi évolutif scanographique prospectif d'une série de 11 patients. Rev Med Interne 2006, 27:196-202.
26. Arnaud L., Haroche J., Piette J.C., Amoura Z. L'artérite de Takayasu: mise au point à propos d'une série monocentrique de 82 patients. Rev Med Interne 2010, 31:208-215.
27. Andrews J., Mason J.C. Takayasu's arteritis - recent advances in imaging offer promise. Rheumatology 2007, 46:6-15.
28. Tso E., Flamm S.D., White R.D., Schvartzman P.R., Mascha E., Hoffman G.S. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002, 46:1634-1642.
29. Desai M.Y., Stone J.H., Foo T.K., Hellmann D.B., Lima J.M., Bluemke D.A. Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. Am J Roentgenol 2005, 184:1427-1431.
30. Sueyoshi E., Sakamoto I., Uetani M. MRI of Takayasu's arteritis: typical appearances and complications. Am J Roentgenol AJR 2006, 187:W569-W575.
31. Raynaud F.R., Huglo D., Steinling M. La tomographie d'émission de positons en medicine interne: applications actuelles et perspectives d'avenir. Rev Med Interne 2006, 27:932-945.
32. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., Alavi A. F-18 FDG uptake in the large arteries. A new observation. Clin Nucl Med 2001, 26:314-319.
33. 18F-FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 2002, 32:70-76.
34. Paulmier B., Duet M., Khayat R., Pierquet-Ghazzar N., Laissy J.P., Maunoury C., et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008, 15:209-217.
35. Tawakol A., Migrino R.Q., Bashian G.G., Bedri S., Vermylen D., Cury R.C., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48:1818-1824.
36. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105:2708-2711.
37. Tatsumi M., Cohade C., Nakamoto Y., Wahl R.L. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 2003, 229:831-837.
38. Schmidt W.A., Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
39. Hoogendoorn E.H., Oyen W.J., van Dijk A.P., van der Meer J.W. Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose. Clin Microbiol Infect 2003, 9:73-76.
40. Kösters K., Bleeker-Rovers C.P., van Crevel R., Oyen W.J., van der Ven A.J. Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection. Infection 2005, 33:387-389.
41. Duet M., Pouchot J., Lioté F., Faraggi M. Tomographie par émission de positons. Quelle place en pathologie ostéoarticulaire?. Rev Rhum 2007, 74:17-26.
42. Walter M.A., Melzer R.A., Schindler C., Müller-Brand J., Tyndall A., Nitzsche E.U. The value of [18F]FDG-PET in the diagnosis of large vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005, 32:674-681.
43. Brodmann M., Lipp R.W., Passath A., Seinost G., Pabst E., Pilger E. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 2004, 43:241-242.
44. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999, 38:444-447.
45. Brodmann M., Passath A., Aigner R., Seinost G., Stark G., Pilger E. F18-FDG-PET as a helpful tool in the diagnosis of giant cell arteritis. Rheumatology 2003, 42:1264-1266.
46. Moosig F., Czech N., Mehl C., Henze E., Zeuner R.A., Kneba M., et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004, 63:870-873.
47. Blockmans D., De Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbarts H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology 2006, 46:672-677.
48. Blockmans D., de Ceuninck L., Vanderschueren S., Knockaert D., Mortelmans L., Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006, 55:131-137.
49. Derdelinckx I., Maes A., Bogaert J., Mortelmans L., Blockmans D. Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol 2000, 55:193-195.
50. Turlakow A., Yeung H.W., Pui J., Macapinlac H., Liebovitz E., Rusch V., et al. Fluorodeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001, 161:1003-1007.
51. Wiest R., Glück T., Schönberger J., Schölmerich J., Eilles C., Müller-Ladner U. Clinical image: occult large vessel vasculitis diagnosed by PET imaging. Rheumatol Int 2001, 20:250.
52. Belhocine T., Kaye O., Delanaye P., Corman V., Baghaie M., Deprez M., et al. Maladie de Horton et atteintes extratemporales: utilité de la tomographie par émission de positons au 18-FDG. À propos de trois observations et d'une revue de la littérature. Rev Med Interne 2002, 23:584-591.
53. Wenger M., Gasser R., Donnemiller E., Erler H., Glossmann H., Patsch J.R., et al. Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18-fluorodeoxyglucose - positron emission tomography. Circulation 2003, 107:923.
54. Pfadenhauer K., Rüll T. Ultrasonographic and FDG-PET imaging in active giant cell arteritis of the carotid arteries. Vasa 2005, 34:269-271.
55. Zalts R., Hamoud S., Bar-Shalom R., Eilam O., Rozin A., Hayek T. Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomography. Am J Med Sci 2005, 330:247-249.
56. Walter M.A., Melzer R.A., Graf M., Tyndall A., Müller-Brand J., Nitzsche E.U. [18F]FDG-PET of giant cell aortitis. Rheumatology 2005, 44:690-691.
57. Kathula S.K., Mantil J., Drehmer T., Patil S.S. Giant cell arteritis mimicking multiple myeloma; diagnosed by PET scan. South Med J 2006, 99:1281-1282.
58. Kwon C.M., Hong Y.H., Chun K.A., Cho I.H., Kim M.J., Shin D.G., et al. A case of silent giant cell arteritis involving the entire aorta, carotid artery and brachial artery screened by integrated PET/CT. Clin Rheumatol 2007, 26:1959-1962.
59. Bajocchi G., Zamorani G., Cavazza A., Pipitone N., Versari A., Boiardi L., et al. Giant cell arteritis of the female genital tract associated with occult temporal arteritis and FDG-PET evidence of large vessel vasculitis. Clin Exp Rheumatol 2007, 25(Suppl 44):36-39.
60. Belloli L., Rodari M., Massarotti M., Conciato L., Chiti A., Marasini B. A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET). Clin Rheumatol 2008, 27:799-801.
61. Kröger K., Antoch G., Goyen M., Freudenberg L.S., Veit P., Janicke I., et al. Positron emission tomography/computed tomography improves diagnostics of inflammatory arteritis. Heart Vessels 2005, 20:179-183.
62. Roldan Valadez E., Vega-Gonzalez I., Valdivieso-Cardenas G. Panaortitis diagnosed by 18F-FDG PET/CT scan in a patient with diffuse large B-cell lymphoma. Rev Esp Med Nucl 2007, 26:232-233.
63. Kataoka H., Atsumi T., Hashimoto T., Horita T., Yasuda S., Koike T. Polymyalgia rheumatica as the manifestation of unclassified aortitis. Mod Rheumatol 2008, 18:105-108.
64. Akin E., Coen A., Momeni N. PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Clin Rheumatol 2009, 28:737-738.
65. Abdul Jalil N., Abdul Rahim N., Md Salleh N., Rossetti C. 18F-FDG positron emission tomography/computed tomography and the « underground map » appearance in imaging Horton's arteritis. Singapore Med J 2008, 49:e178-e182.
66. Schäfer V.S., Warrington K.J., Williamson E.E., Kermani T.A. Delayed diagnosis of biopsy-negative giant cell arteritis presenting as fever of unknown origin. J Gen Intern Med 2009, 24:532-536.
67. Tato F., Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 2006, 44:176-182.
68. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000, 108:246-249.
69. Meller J., Strutz F., Siefker U., Scheel A., Sahlmann C.O., Lehmann K., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
70. Scheel A.K., Meller J., Vosshenrich R., Kohlhoff E., Siefker U., Müller G.A., et al. Diagnosis and follow-up of aortitis in the elderly. Ann Rheum Dis 2004, 63:1507-1510.
71. Hautzel H., Sander O., Heinzel A., Schneider M., Müller H.W. Assessment of large vessel involvement in giant cell arteritis with 18-FDG PET: introducing an ROC-analysis based cut-off ratio. J Nucl Med 2008, 49:1107-1113.
72. Dejaco C., Duftner C., Wipfler E., Schirmer M. 18F-Flourodeoxyglucose positron emission tomography in polymyalgia rheumatica: novel insight into complex pathogenesis but questionable use in predicting relapses. Rheumatology 2007, 46:559-560.
73. Hara M., Goodman P.C., Leder R.A. FDG-PET finding in early-phase. Takayasu arteritis. J Comput Assist Tomogr 1999, 23:16-18.
74. Kaku B., Higuchi T., Kanaya H., Horita Y., Yamazaki T., Uno Y., et al. Usefulness of fluorine-18-fluorodeoxyglucose positron emission tomography in a patient with Takayasu's arteritis associated with antiphospholipid syndrome. Int Heart J 2006, 47:311-317.
75. 18FDG au cours de l'artérite de Takayasu: un marqueur d'activité de la maladie. Rev Med Interne 2006, 27:478-481.
76. Umekita K., Takajo I., Miyauchi S., Tsurumura K., Ueno S., Kusumoto N., et al. 18F-fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease. Mod Rheumatol 2006, 16:243-247.
77. Meave A., Soto M.E., Reyes P.A., Cruz P., Talayero J.A., Sierra C., et al. Pre-pulseless Takayasu arteritis evaluated with 18F-FDG Positron emission tomogtraphy and gadolinium-enhanced magnetic resonance imaging. Tex Heart Inst J 2007, 34:466-469.
78. Iwabu M., Yamamoto Y., Dobashi H., Kameda T., Kittaka K., Nishiyama Y. F18-FDG-PET findings of Takayasu arteritis before and after immunosuppressive therapy. Clin Nucl Med 2008, 33:872-873.
79. Meller J., Grabbe E., Becker W., Vosshenrich R. Value of F-18-FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur radiol 2003, 13:400-405.
80. Andrews J., Al-Nahhas A., Pennel D.J., Hossain M.S., Davies K.A., Haskard D.O., et al. Noninvasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 2004, 63:995-1000.
81. Webb M., Chambers A., Al-Nahhas A., Mason J.C., Maudlin L., Rahman L., et al. The role of 18-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004, 31:627-634.
82. Kobayashi Y., Ishii K., Oda K., Nariai T., Tanaka Y., Ishiwata K., et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005, 46:917-922.
83. Arnaud L., Haroche J., Malek Z., Archambaud F., Gambotti L., Grimon G., et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?. Arthritis Rheum 2009, 60:1193-1200.
84. Bleeker-Rovers C.P., Bredie S.J.H., van den Meer J.W.N., Cortstens F.H.M., Oyen W.J.G. Fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004, 116:50-53.
85. Obermeier F., Herold T., Schönberger J., Tarner I., Eilles C., Schölmerich J., et al. Vasculitis of the aortic arch and cardiac valves as the cause of relapsing fever of unknown origin in an elderly, white man. Clin Rheumatol 2006, 25:923-925.
86. Maruoka H., Koga T., Takeo M., Honda S., Yuge K., Fukuda T., et al. Increased splenic fluorodeoxyglucose uptake in a patient with granulomatous angitis. Intern Med 2007, 46:909-911.
87. Vandergheynst F., Goldman S., Cogan E. Wegener's granulomatosis overlapping with Takayasu's arteritis revealed by FDG-PET scan. Eur J Intern Med 2007, 18:148-149.
88. Jouret F., Noirhomme S., Grandin C., Lonneux M., Godfraind C., Lambert M., et al. Atteinte cérébrale au cours d'une maladie de Wegener. Rev Med Interne 2008, 29:912-916.
89. Balink H., Bruyn G.A.W. The role of PET/CT in Cogan's syndrome. Clin Rheumatol 2007, 26:2177-2179.
90. Ostuda H., Morita N., Yamashita K., Nishitani H. FDG-PET/CT for diagnosis and follow-up of vasculitis. J Med Invest 2007, 54:345-349.
91. De Geeter F., Vandecasteele S.J. Fluorodeoxyglucose PET in relapsing polychondritis. N Engl J Med 2008, 358:536-537.
92. Salvarani C., Pipitone N., Versari A., Vaglio A., Serafini D., Bajocchi G., et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005, 53:298-303.
93. Sakalihasan N., Van Damme H., Gomez P., Rigo P., Lapiere C.M., Nusgens B., et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 2002, 23:431-436.
94. Girszyn N., Arnaud L., Villain D., Kahn J.E., Piette A.M., Bletry O. Intérêt de la tomographie par émission de positons couplée au scanner dans la maladie d'Erdheim-Chester. Rev Med Interne 2007, 28:770-774.
95. Haroche J., Arnaud L., Malek Z., Maksud P., Archambault F., Kas A., et al. Intérêt du 18-FDG-TEP scanner au cours de la maladie d'Erdheim-Chester: à propos d'une série monocentrique de 25 patients. Rev Med Interne 2008, 29(Suppl 1):S28-29.
96. Meller J., Sahlmann C.O., Scheel A.K. 18-FDG and PET/CT in fever of unknown origin. J Nucl Med 2007, 48:35-45.
97. Dupond J.L. Diagnostic des fièvres prolongées inexpliquées: tactiques et stratégies. Rev Med Interne 2008, 29:946-956.
98. 18F]FDG imaging with a double head coincidence camera (DHCC) and Ga-67 citrate SPECT. Eur J Nucl Med 2000, 27:1617-1625.
99. Blockmans D., Knockaert D., Maes A., De Caestecker J., Stroobants S., Bobbaers H., et al. Clinical value of [18-F]fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001, 32:191-196.
100. Lorenzen J., Buchert R., Bohuslavizki K.H. Value of FDG-PET in patients with fever of unknown origin. Nucl Med Commun 2001, 22:779-783.
101. Kjaer A., Lebech A.M., Eigtved A., Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 2004, 31:622-626.
102. Buysschaert I., Vanderschueren S., Blockmans D., Mortelmans L., Knockaert D. Contribution of [18]fluorodeoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 2004, 15:151-156.
103. Bleeker-Rovers C.P., Vos F.J., Mudde A.H., Dofferhoff A.S., de Geus-Oei L.F., Rijnders A.J., et al. A prospective multicentre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging 2007, 34:694-703.
104. Knockaert D.C., Vanneste Lj, Bobbaers H.J. Fever of unknown origin in elderly patients. J Am Geriatr Soc 1993, 41:1187-1192.
105. Tal S., Guller V., Gurevich A., Levi S. Fever of unknown origin in the elderly. J Intern Med 2002, 252:295-304.
106. 18FDG PET for the diagnosis of giant cell arteritis - a response to the article of Brodmann et al. Rheumatology 2004, 43:675-676.
107. 18F-FDG-TEP) pour le diagnostic des fièvres et syndromes inflammatoires prolongés d'origine indéterminée. Med Ther 2008, 14:306-313.
108. Meller J., Salhmann C.O., Gürocak O., Liersch T., Meller B. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging. 2009, 53:51-63.
109. de Leeuw K., Bijl M., Jager P.L. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitis. Clin Exp Rheumatol 2004, 22(6 Suppl 36):S21-S26.
110. Cimmino M.A., Zampogna G., Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?. Rheumatology 2008, 47:926-927.
111. Both M., Ahmadi-Simab K., Reuter M., Dourvos O., Fritzer E., Ullrich S., et al. MRI and FDG-TEP in the assessment of inflammatory aortic arch syndrome in complicated course of giant cell arteritis. Ann Rheum Dis 2008, 67:1030-1033.
112. Blockmans D., Coudyzer W., Vanderschueren S., Stroobants S., Loeckx D., Heye S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008, 47:1179-1184.
113. Vaglio A., Greco P., Versari A., Filice A., Cobelli R., Manenti L., et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent " scar"? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005, 23:231-234.